Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aldeyra Therapeutics

5.07
+0.04000.80%
Post-market: 5.070.00000.00%18:39 EDT
Volume:568.80K
Turnover:2.84M
Market Cap:303.67M
PE:-5.99
High:5.11
Open:5.01
Low:4.85
Close:5.03
52wk High:7.20
52wk Low:1.14
Shares:59.90M
Float Shares:48.48M
Volume Ratio:0.79
T/O Rate:1.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8470
EPS(LYR):-0.9389
ROE:-65.91%
ROA:-31.58%
PB:5.49
PE(LYR):-5.40

Loading ...

Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024

Major Issues Report

Form 8-K - Current report
Jan 04, 2024

Major Issues Report

Form 8-K - Current report
Dec 22, 2023

Major Issues Report

Form 8-K - Current report
Dec 19, 2023

Major Issues Report

Form 8-K - Current report
Nov 28, 2023

Major Issues Report

Form 8-K - Current report
Nov 04, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 01, 2023

Major Issues Report

Form 8-K - Current report
Oct 19, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Oct 16, 2023

Major Issues Report

Form 8-K - Current report
Oct 04, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 04, 2023

Major Issues Report

Form 8-K - Current report
Jun 29, 2023

Major Issues Report

Form 8-K - Current report
Jun 27, 2023

Major Issues Report

Form 8-K - Current report
Jun 22, 2023

Major Issues Report

Form 8-K - Current report
Jun 15, 2023

Major Issues Report

Form 8-K - Current report
May 04, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]